---
title: "Thioctic Acid (Alpha Lipoic Acid) Market Size by Player, Region, Type, Application and Sales Channel 2025-2032"
datePublished: Sat Jul 26 2025 02:42:15 GMT+0000 (Coordinated Universal Time)
cuid: cmdjn9zmw000g02l8fiatglg0
slug: thioctic-acid-alpha-lipoic-acid-market-size-by-player-region-type-application-and-sales-channel-2025-2032

---

# Thioctic Acid (Alpha Lipoic Acid) Market Size by Player, Region, Type, Application and Sales Channel 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global thioctic acid (alpha lipoic acid) market size was valued at <strong>USD 567.4 million in 2024</strong>. The market is projected to grow from <strong>USD 612.2 million in 2025 to USD 1.02 billion by 2032, exhibiting a CAGR of 7.3%</strong> during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/113118/thioctic-acid-market">
            https://www.24chemicalresearch.com/download-sample/113118/thioctic-acid-market</a></b></div><br><p>
</p><p>Thioctic acid, commonly known as alpha-lipoic acid (ALA), is a powerful antioxidant naturally produced in the body and found in certain foods. This organosulfur compound plays a crucial role in energy metabolism and oxidative stress reduction, making it valuable in pharmaceutical and nutraceutical applications. The compound exists in two enantiomeric forms (R-ALA and S-ALA), with R-ALA being the biologically active form.</p><p>
</p><p>Market growth is driven by increasing consumer awareness about antioxidant benefits, rising demand for anti-aging supplements, and expanding applications in diabetes management. Pharmaceutical-grade ALA dominates revenue share due to its therapeutic applications, while food-grade variants are gaining traction in functional foods and dietary supplements. Asia-Pacific represents the fastest-growing regional market, fueled by expanding healthcare infrastructure and rising disposable incomes in emerging economies.</p><p>
</p><p><img alt="thioctic acid (alpha lipoic acid) market 24chemicalresearch" src="https://www.24chemicalresearch.com/assets/report-images/p0990-.webp" style="height:470px; width:750px"></p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Demand for Nutraceuticals and Dietary Supplements Boosts Market Growth</strong></p><p>
</p><p>Global thioctic acid market is witnessing substantial growth due to increasing consumer awareness about preventive healthcare and the rising demand for nutraceuticals. With over 45% of adults in developed countries regularly consuming dietary supplements, alpha lipoic acid has gained prominence for its antioxidant properties and role in managing blood sugar levels. The nutraceutical sector's CAGR of 7.5% between 2024-2032 directly benefits thioctic acid producers as formulations incorporate this ingredient for metabolic support. Established manufacturers are expanding production capacities, with several Chinese facilities increasing output by 20-25% annually to meet Western market demands.</p><p>
</p><p style="text-align:center"><strong>Therapeutic Applications in Diabetes Management Drive Pharmaceutical Adoption</strong></p><p>
</p><p>Pharmaceutical applications account for approximately 38% of thioctic acid consumption globally, primarily for diabetic neuropathy treatment. With diabetes prevalence projected to affect 700 million people by 2032, medical-grade alpha lipoic acid demand grows proportionally. Clinical studies validate its efficacy in symptom reduction, prompting healthcare providers to incorporate it into treatment protocols. Regulatory approvals across major markets have accelerated, with recent fast-track designations in emerging economies where diabetes rates are climbing fastest. This therapeutic demand creates stable, high-value market segments less susceptible to economic fluctuations than consumer health products.</p><p>
</p><p style="text-align:center"><strong>Anti-Aging Cosmetics Trend Expands Application Scope</strong></p><p>
</p><p>The <strong>USD12 billion </strong>cosmeceutical industry's shift toward science-backed anti-aging ingredients presents significant opportunities. Thioctic acid's ability to neutralize multiple free radical types makes it increasingly valuable in premium skincare formulations, particularly in Asia-Pacific markets where preventative aging care begins earlier. Market intelligence indicates 18% year-over-year growth in alpha lipoic acid-containing cosmetic launches since 2022. Formulators value its synergies with vitamins C and E, creating demand for high-purity (&gt;99%) cosmetic-grade material. This diversification beyond traditional health applications provides manufacturers with higher-margin revenue streams while mitigating reliance on any single end-use sector.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Price Volatility of Raw Materials Impacts Production Stability</strong></p><p>
</p><p>The thioctic acid market faces considerable pressure from fluctuating raw material costs, particularly octanoic acid derivatives which account for 60-70% of production expenses. Global supply chain disruptions since 2024 have caused 30-40% price swings in key precursors, forcing manufacturers to either absorb margins or implement frequent price adjustments. These inconsistencies particularly challenge smaller producers lacking long-term supply contracts or vertical integration. Seasonal agricultural factors affecting octanoic acid availability further complicate production planning, with Q3 typically witnessing 15-20% cost increases that ripple through the value chain.</p><p>
</p><p style="text-align:center"><strong>Regulatory Heterogeneity Challenges Global Market Expansion</strong></p><p>
</p><p>Divergent regulatory classifications of alpha lipoic acid across jurisdictions create substantial market access barriers. While designated as a drug in some countries, others classify it as a supplement ingredient with varying purity requirements. The European Union's Novel Food regulations versus the U.S. GRAS status exemplify this fragmentation, requiring manufacturers to maintain separate production batches and documentation. Compliance costs for serving multiple regulatory environments can reach 22-25% of total operating expenses for mid-sized producers, deterring market entry and limiting competitive pressure that could benefit consumers through price reductions.</p><p>
</p><p style="text-align:center"><strong>Counterfeit Products Erode Branded Market Share</strong></p><p>
</p><p>An estimated 12-15% of global thioctic acid sales involve counterfeit or adulterated products, disproportionately affecting online distribution channels. These products often contain as little as 30-40% of labeled alpha lipoic acid content, mixed with inexpensive fillers. Beyond revenue losses, this trend creates consumer safety risks and damages overall market credibility. Industry analyses indicate counterfeit incidents increase 8-10% annually, with fragmentation in Asian manufacturing hubs complicating enforcement efforts. Brand protection measures now consume 5-7% of leading manufacturers' marketing budgets, resources that otherwise could fuel innovation or market expansion initiatives.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Economies Present Untapped Growth Potential</strong></p><p>
</p><p>Southeast Asian and Latin American markets demonstrate accelerating thioctic acid adoption, with current per capita consumption at just 15-20% of developed market levels. Rising middle-class healthcare expenditure and increasing diabetes prevalence create ideal conditions for market penetration. Strategic partnerships with local distributors could yield 18-22% annual growth rates in these regions through 2032. India's pharmaceutical sector alone is projected to require 40% more alpha lipoic acid by 2028 as it expands neuropathy treatment accessibility. Early entrants establishing manufacturing partnerships or regulatory footholds now will gain disproportionate advantages as these markets mature.</p><p>
</p><p style="text-align:center"><strong>Bioavailability Enhancement Technologies Enable Premium Products</strong></p><p>
</p><p>Advanced formulation technologies present lucrative opportunities to differentiate products and justify price premiums. Nano-emulsification and liposomal delivery systems can improve alpha lipoic acid's bioavailability by 300-400%, addressing a key limitation of conventional preparations. Several pharmaceutical companies have patented these enhanced formulations, achieving 25-30% higher wholesale prices. The technology transfer potential to nutraceutical applications could reshape the consumer market, with early clinical data suggesting superior efficacy in metabolic support. Investing in bioavailability research and patent-protected formulations offers manufacturers sustainable competitive advantages beyond cost-based competition.</p><p>
</p><p style="text-align:center"><strong>Sustainable Production Methods Align With Industry Megatrends</strong></p><p>
</p><p>Green chemistry innovations in thioctic acid synthesis respond to growing environmental concerns throughout the supply chain. Bio-catalytic production methods reduce hazardous waste generation by 60-70% compared to conventional processes, while cutting energy consumption by approximately 40%. Sustainability-conscious buyers increasingly favor responsibly produced ingredients, with preferential procurement policies in Europe and North America driving this shift. Lifecycle assessments demonstrate these methods' commercial viability, with production cost premiums of just 8-12% offset by brand equity gains and regulatory compliance benefits. Early adopters position themselves favorably for impending environmental regulations while appealing to ethically motivated consumers.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Intellectual Property Disputes Hinder Innovation Investment</strong></p><p>
</p><p>The thioctic acid sector faces increasing patent litigation, particularly regarding synthetic process patents and formulation technologies. Legal costs for defending intellectual property average $2-3 million per case, a significant burden for small and medium enterprises. These disputes create market uncertainty, with some manufacturers delaying product launches or process improvements pending litigation outcomes. The lack of unified patent enforcement mechanisms across key markets exacerbates this challenge, requiring separate legal actions in different jurisdictions. This environment discourages research and development spending, despite the clear technological opportunities available in bioavailability enhancement and sustainable production.</p><p>
</p><p style="text-align:center"><strong>Substitute Antioxidants Intensify Competitive Pressure</strong></p><p>
</p><p>Emerging antioxidant compounds challenge alpha lipoic acid's market position, particularly in consumer health segments. Substances like ergothioneine and pyrroloquinoline quinone (PQQ) gain traction for their comparable or superior bioavailability profiles. Clinical comparisons increasingly inform formulation decisions, with some supplement manufacturers shifting 15-20% of their antioxidant budgets to these newer options. While thioctic acid retains advantages in diabetes applications, the broader antioxidant market's fragmentation requires producers to demonstrate unique value propositions through clinical substantiation and targeted marketing campaigns.</p><p>
</p><p style="text-align:center"><strong>Trade Policy Uncertainties Disrupt Supply Chains</strong></p><p>
</p><p>Geopolitical tensions and shifting trade policies introduce volatility into thioctic acid distribution networks. Tariff fluctuations between major producing and consuming countries have reached 8-12% swings annually since 2024, forcing frequent supply chain reconfigurations. The concentration of active pharmaceutical ingredient production in specific regions creates vulnerabilities, with trade disputes potentially interrupting 30-40% of global supply. Manufacturers must balance cost efficiency against supply security, often maintaining dual sourcing strategies that increase operational complexity by 25-30%. These trade dynamics particularly disadvantage smaller players lacking the scale to absorb additional compliance costs or maintain diversified supplier networks.</p><p>
<strong>THIOCTIC ACID (ALPHA LIPOIC ACID) MARKET TRENDS</strong></p><p>
<strong>Growing Demand for Antioxidant Supplements Drives Market Expansion</strong></p><p>
</p><p>Global thioctic acid (alpha lipoic acid) market is experiencing robust growth, primarily fueled by increasing consumer awareness of antioxidant benefits and rising demand for anti-aging solutions. As a potent antioxidant with both water- and fat-soluble properties, alpha lipoic acid has gained significant traction in health supplements, with the nutraceutical sector accounting for over 45% of total consumption. The rising prevalence of chronic conditions such as diabetes and neurodegenerative disorders has further accelerated adoption rates, particularly in developed markets where preventive healthcare spending continues to rise. Emerging pharmaceutical applications in treating diabetic neuropathy have shown promising clinical trial results, expanding the compound's therapeutic potential beyond traditional supplement formulations.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Pharmaceutical Innovations</strong></p><p>
</p><p>Pharmaceutical companies are increasingly incorporating alpha lipoic acid into novel drug formulations, particularly for metabolic and neurological applications. Recent clinical studies demonstrate its efficacy in improving insulin sensitivity and reducing oxidative stress markers by up to 30% in diabetic patients. The compound's neuroprotective properties are also being explored for Alzheimer's and Parkinson's disease treatments, with several Phase III trials underway. This therapeutic diversification is creating new revenue streams while simultaneously reinforcing demand in traditional supplement segments.</p><p>
<strong>Asia-Pacific Emerges as High-Growth Manufacturing Hub</strong></p><p>
</p><p>Asia-Pacific region has become the epicenter of thioctic acid production, with China accounting for approximately 60% of global manufacturing capacity. Local producers benefit from established chemical synthesis expertise and cost advantages in raw material procurement. While domestic regulations on supplement ingredients remain less stringent than in Western markets, regional manufacturers are increasingly investing in GMP-certified facilities to access premium export markets. This geographic shift is transforming supply chain dynamics, with multinational brands diversifying their supplier base to mitigate geopolitical risks and ensure consistent quality standards across regions. The competitive landscape continues to evolve as regional players like Tonghe and Shyndec expand their international footprint through strategic partnerships.</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Strategic Expansion and Product Innovation Drive Market Competition</strong></p><p>
</p><p>Global thioctic acid (alpha lipoic acid) market features a moderately fragmented competitive landscape, with both established pharmaceutical manufacturers and emerging nutraceutical companies vying for market share. <strong>Tonghe</strong> and <strong>Fushilai Pharmaceutical</strong> currently dominate the Asian market, leveraging their extensive production capabilities and cost advantages in raw material sourcing. These companies accounted for approximately <strong>28% of the regional market share collectively in 2024</strong>, benefiting from growing domestic demand and export opportunities.</p><p>
</p><p>While Asian manufacturers lead in production volume, Western players like <strong>Maidesen</strong> and <strong>Infa Group</strong> are gaining traction through premium product positioning and clinical research investments. The latter has particularly strengthened its European footprint through partnershipswith local distributors, capturing nearly <strong>15% of the European nutraceutical-grade alpha lipoic acid market</strong> last year.</p><p>
</p><p>Recent industry movements show <strong>Taike Biological</strong> making strategic inroads into North America through FDA-approved manufacturing facilities, while <strong>DKY Technology</strong> focuses on patented encapsulation technologies to enhance product stability. These technological advancements are expected to reshape competitive dynamics through 2032, particularly in high-growth segments like anti-aging formulations.</p><p>
</p><p>The market also observes increasing vertical integration, with <strong>Shyndec</strong> recently acquiring raw material suppliers to secure supply chains. Such consolidation activities, coupled with R&amp;D investments in novel delivery systems (liposomal and nano-formulations), indicate the industry's shift toward value-added products beyond conventional powder and capsule forms.</p><p>
<strong>List of Key Thioctic Acid (Alpha Lipoic Acid) Companies Profiled</strong></p><p>
</p><p>Tonghe (China)</p><p><strong>Shyndec (China)</strong></p><p>Fushilai Pharmaceutical (China)</p><p>Maidesen (Germany)</p><p>Taike Biological (China)</p><p><strong>DKY Technology (China)</strong></p><p>Haoxiang Bio (China)</p><p>Infa Group (Italy)</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Medical Grade Dominates the Market Due to Increasing Pharmaceutical Applications</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Medical Grade</p><p>
	</p><p>Primarily used in pharmaceutical formulations and supplements</p><p>Food Grade</p><p>
	</p><p>Commonly incorporated in dietary supplements and functional foods</p><p>Others</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Pharmaceutical Segment Leads Owing to Extensive Therapeutic Utilization</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Health Care</p><p>Pharmaceutical</p><p>Others</p><p>
<strong>By Sales Channel</strong></p><p>
</p><p><strong>Distribution Channel Gains Traction for Wider Market Reach</strong></p><p>
</p><p>The market is segmented based on sales channel into:</p><p>
</p><p>Direct Channel</p><p>Distribution Channel</p><p>
<strong>Regional Analysis: Thioctic Acid (Alpha Lipoic Acid) Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
North American market for thioctic acid is characterized by strong demand driven by the rising prevalence of diabetes and neurological disorders, coupled with high disposable incomes and well-established healthcare infrastructure. The U.S. dominates consumption, accounting for over 80% of regional market share. Growth is further supported by increasing adoption of dietary supplements, with the nutraceutical industry projected to expand at a CAGR of 6.5% through 2032. However, stringent FDA regulations for pharmaceutical-grade products pose formulation challenges for manufacturers. Recent trends show growing preference for R-lipoic acid (the biologically active enantiomer) despite its higher cost, reflecting premiumization in consumer health segments.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe represents the second-largest market globally, with Germany and France being key consumption hubs. The region benefits from advanced research on thioctic acid's applications in diabetic neuropathy treatment and indigenous production capabilities. EU health claims regulations (EC No 1924/2006) strictly govern antioxidant benefit assertions, influencing product labeling strategies. Sustainability concerns are reshaping the competitive landscape, with manufacturers like Infa Group investing in green chemistry processes to reduce production waste by 30% by 2025. The medical grade segment holds majority share due to robust clinical usage, though price sensitivity in Southern Europe favors generic formulations.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
APAC is the fastest-growing regional market, projected to exceed <strong>USD280 million</strong> by 2032, led by China's pharmaceutical expansion and India's thriving nutraceutical sector. Local manufacturers including Shyndec and Tonghe control approximately 60% of regional supply through cost-competitive production. While food-grade thioctic acid dominates volume sales due to supplement applications, medical grade demand is rising with increasing diabetes prevalence (affecting 11% of China's adult population). Japan maintains premium positioning with focus on high-purity R-lipoic acid formulations for anti-aging applications. However, inconsistent quality standards across emerging markets remain a key challenge.</p><p>
</p><p><strong>South America</strong></p><p>
Market growth in South America is constrained by economic instability but shows potential in Brazil and Argentina where diabetic populations exceed 15 million. Pharmaceutical applications drive 70% of demand, though distribution challenges limit rural accessibility. The region relies heavily on imports, particularly from Chinese suppliers, creating price volatility. Recent developments include Brazil's ANVISA streamlining supplement regulations, which may stimulate local production. Economic recovery post-COVID could accelerate CAGR to 5.8% through 2032, though inflation continues to impact consumer spending on premium health products.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
MEA exhibits nascent but promising growth, concentrated in GCC countries and South Africa. The UAE and Saudi Arabia are emerging as regional hubs, with thioctic acid imports growing 12% annually, primarily for diabetes management. High healthcare expenditure in GCC (averaging <strong>USD2,200 </strong>per capita) supports pharmaceutical adoption, while Africa's market remains constrained by limited awareness. Religious tourism in Saudi Arabia is creating ancillary demand for anti-aging supplements. Long-term potential exists through healthcare modernization programs like Saudi Vision 2030, though political instability in some regions continues to deter investment.</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Thioctic Acid (Alpha Lipoic Acid), covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Thioctic Acid (Alpha Lipoic Acid) companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Thioctic Acid (Alpha Lipoic Acid) Market?</strong></p><p>
</p><p><strong>-&gt; </strong>Global thioctic acid (alpha lipoic acid) market size was valued at USD 567.4 million in 2024. The market is projected to grow from USD 612.2 million in 2025 to USD 1.02 billion by 2032, exhibiting a CAGR of 7.3% during the forecast period.</p><p>
<strong>Which key companies operate in Global Thioctic Acid (Alpha Lipoic Acid) Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Tonghe, Shyndec, Fushilai Pharmaceutical, Maidesen, Taike Biological, DKY Technology, Haoxiang Bio, and Infa Group</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for dietary supplements, increasing applications in pharmaceuticals, and growing awareness about antioxidant benefits</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> is the fastest-growing region, accounting for <strong>42% of the global market share in 2024</strong>, while <strong>North America</strong> remains the largest consumer market.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>increased R&amp;D in diabetes management applications, expansion of nutraceutical applications, and development of high-purity formulations</strong>.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/113118/thioctic-acid-market">
            https://www.24chemicalresearch.com/reports/113118/thioctic-acid-market</a></b></div><br>
            <b>Table of Content:</b><p>Table of Contents<br />
<br />
Chapter 1 Thioctic Acid (Alpha Lipoic Acid) Market Overview<br />
    1.1 Thioctic Acid (Alpha Lipoic Acid) Definition<br />
    1.2 Global Thioctic Acid (Alpha Lipoic Acid) Market Size Status and Outlook (2015-2030)<br />
    1.3 Global Thioctic Acid (Alpha Lipoic Acid) Market Size Comparison by Region (2015-2030)<br />
    1.4 Global Thioctic Acid (Alpha Lipoic Acid) Market Size Comparison by Type (2015-2030)<br />
    1.5 Global Thioctic Acid (Alpha Lipoic Acid) Market Size Comparison by Application (2015-2030)<br />
    1.6 Global Thioctic Acid (Alpha Lipoic Acid) Market Size Comparison by Sales Channel (2015-2030)<br />
    1.7 Thioctic Acid (Alpha Lipoic Acid) Market Dynamics (COVID-19 Impacts)<br />
        1.7.1 Market Drivers/Opportunities<br />
        1.7.2 Market Challenges/Risks<br />
        1.7.3 Market News (Mergers/Acquisitions/Expansion)<br />
        1.7.4 COVID-19 Impacts on Current Market<br />
        1.7.5 Post-Strategies of COVID-19 Outbreak<br />
Chapter 2 Thioctic Acid (Alpha Lipoic Acid) Market Segment Analysis by Player<br />
    2.1 Global Thioctic Acid (Alpha Lipoic Acid) Sales and Market Share by Player (2018-2020)<br />
    2.2 Global Thioctic Acid (Alpha Lipoic Acid) Revenue and Market Share by Player (2018-2020)<br />
    2.3 Global Thioctic Acid (Alpha Lipoic Acid) Average Price by Player (2018-2020)<br />
    2.4 Players Competition Situation & Trends<br />
    2.5 Conclusion of Segment by Player<br />
Chapter 3 Thioctic Acid (Alpha Lipoic Acid) Market Segment Analysis by Type<br />
    3.1 Global Thioctic Acid (Alpha</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/113118/thioctic-acid-market">
            https://www.24chemicalresearch.com/reports/113118/thioctic-acid-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>